Genmab A (GMAB) Amortizatization of Intangibles (2024 - 2026)

Genmab A (GMAB) posted Amortizatization of Intangibles of $13.0 million for Q1 2026, up 18.18% on a QoQ basis from $11.0 million in Q3 2025, and up 225.0% year-over-year from $4.0 million in Q1 2025.

Genmab A (GMAB) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends

Genmab A's Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $13.0 million for Q1 2026.

  • Quarterly Amortizatization of Intangibles rose 225.0% year-over-year to $13.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.0 million (up 105.88% YoY) and the FY2025 annual result came in at $16.0 million, up 45.45% from the prior year.
  • Amortizatization of Intangibles was $13.0 million for Q1 2026 at Genmab A, up from $11.0 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $13.0 million in Q1 2026 and bottomed at $2.0 million in Q1 2024.
  • A 3-year average of $6.9 million and a median of $7.0 million in 2024 frame the typical range for Amortizatization of Intangibles.
  • Annual changes were most pronounced in 2025 — Amortizatization of Intangibles jumped 57.14% — and 2026, when it jumped 225.0%.
  • Genmab A's Amortizatization of Intangibles stood at $7.0 million in 2024, then soared by 57.14% to $11.0 million in 2025, then rose by 18.18% to $13.0 million in 2026.
  • Business Quant data shows GMAB's Amortizatization of Intangibles at $13.0 million in Q1 2026, $11.0 million in Q3 2025, and $7.0 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Genmab A 1.87 Bn 349.77 Mn 831.00 Mn 13.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 13.00 Mn
Mar 31, 2026 13.00 Mn
Sep 30, 2025 11.00 Mn
Sep 30, 2025 11.00 Mn
Jun 30, 2025 7.00 Mn
Jun 30, 2025 7.00 Mn
Mar 31, 2025 4.00 Mn
Mar 31, 2025 4.00 Mn
Sep 30, 2024 7.00 Mn
Sep 30, 2024 7.00 Mn
Jun 30, 2024 4.00 Mn
Jun 30, 2024 4.00 Mn
Mar 31, 2024 2.00 Mn
Mar 31, 2024 2.00 Mn